▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2102 by analyst upside · 2026-09-28
ZTS
Zoetis Inc.
Healthcare · Market Cap $29B · P/E 11.6x
ANALYST PRICE TARGET
+35.1%
implied upside to consensus target
Current Price $71.05
Consensus Target $96.0
Bull Target $155.0
Bear Target $80.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
3
Hold
7
Sell
1
52-Week Low $69.52
52-Week High $148.79
YTD Return -42.7%
FUNDAMENTALS
Market Cap $29B
P/E Ratio (TTM) 11.6x
Forward P/E 10.9x
EPS (TTM) $6.13
PEG Ratio 6.61
Dividend Yield 2.98%
Revenue (TTM) $9.5B
Profit Margin 27.7%
52-WEEK RANGE
52-Week Low $69.52
52-Week High $148.79
Current Price $71.05
Bear Target $80.0
Bull Target $155.0
● Now $71.05 ● Target $96.0
TRADING DATA
Avg Volume 5.7M
YTD Return -42.7%
Analyst Count 14
Consensus Buy
Upside to Target +35.1%
Last Updated 2026-09-28

ANALYST SUMMARY

Zoetis Inc. (ZTS) is currently trading at $71.05 with a Wall Street consensus price target of $96.0, implying potential upside of 35.1% over the next 12 months. 14 analysts currently cover ZTS, with a consensus rating of Buy - 43% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $155.0, while the most cautious has a target of $80.0.

ZTS operates in the Healthcare sector with a market capitalisation of $29B. The stock is down 42.7% year-to-date and is currently trading near the lower end of its 52-week range of $69.52 – $148.79.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ZTS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen - Reiterated
Buy → Buy 2026-08-25 Building track record
Stifel - Reiterated
Hold → Hold 2026-08-20 Building track record
Citigroup - Reiterated
Buy → Buy 2026-08-11 Building track record
BNP Paribas - Reiterated
Outperform → Outperform 2026-08-11 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2026-08-10 14% win rate (7 calls)
UBS - Reiterated
Neutral → Neutral 2026-08-07 33% win rate (6 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-08-07 43% win rate (7 calls)
William Blair ↓ Downgrade
Outperform → Market Perform 2026-08-06 44% win rate (9 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
37
out of 100
Coverage depth
21/30
Consensus clarity
9/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →